Participants received a daily tweet over a period of one-month with educational messages about HPV vaccine and cervical cancer
NCT Number: NCT04023955
Promoting HPV Vaccine Through Twitter
This study assessed the feasibility of implementing a one-month Twitter campaign to promote knowledge about the human papillomavirus (HPV) vaccine among low-income women living in public housing.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–26 year
Sex eligibility
Female
Study type
Observational
About this study
Investigators recruited a convenience sample (n=35) of women ages 18-26 years who resided in public housing in Massachusetts. Investigators assessed the feasibility and acceptability of the campaign. Online assessed changes in HPV knowledge, attitudes, and vaccine intentions before and after the campaign.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
English-speaking women Age18-26 years Residents of public housing in two Massachusetts cities
Treatment and study plan
Primary outcomes
-
Measure of Humanpapilloma VirusVaccine Knowledge
Time frame: 3 months
13 items that assess knowledge about HPV, the HPV vaccine, and cervical cancer; HPV and cervical cancer risk factors and HPV transmission. Score from 0-100% with higher scores indicating greater knowledge
Sponsors and collaborators
Lead sponsor
Tufts University
Other
Registry information
Official study title
Feasibility of a Twitter Campaign to Promote HPV Vaccine Uptake Among Racially/Ethnically Diverse Young Adult Women Living in Public Housing
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jul 18, 2019
- Registry last updated
- Sep 4, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Hashtag HPV: HPV Vaccine Twitter Education Program
NCT05204030
Human Papilloma Virus, Infections
Fayetteville, Arkansas, United States
View Trial DetailsTORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
NCT03729518
Carcinoma, Carcinoma, Squamous Cell
Philadelphia, Pennsylvania, United States
View Trial DetailsA Proximity-incentive Strategy for Cervical Cancer Screening
NCT04716127
Cervical Cancer, Female Urogenital Diseases
Montpellier, Herault, France
View Trial DetailsGARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
NCT03943875
Efficacy, Human Papilloma Virus
Galveston, Texas, United States
View Trial Details